United StatesA bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed Senate
- Passed House
- To President
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Jul 21Introduced in SenateLatest
- Jul 21Read twice and referred to the Committee on Health, Education, Labor, and Pensions.Introduced